Treatment for Post-Surgical Skin Infection Unresponsive to Amoxicillin
Rationale for Treatment Change
- Post-surgical skin infections unresponsive to amoxicillin likely involve resistant organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA), which has emerged as the leading cause of postoperative infections 2
- Nosocomial postoperative infections require coverage against a broader spectrum of pathogens including Pseudomonas aeruginosa, Enterobacter species, Proteus species, MRSA, enterococci, and potentially anaerobes 3
- Treatment failure with amoxicillin suggests either resistant organisms or a polymicrobial infection requiring broader coverage 4
Recommended Treatment Options
- The Infectious Diseases Society of America recommends piperacillin-tazobactam or ceftriaxone plus metronidazole for intestinal/genitourinary surgical site infections 1
- Vancomycin or linezolid is recommended if MRSA is suspected in trunk/extremity surgical site infections 6, 7
- For severe infections, vancomycin plus piperacillin-tazobactam or linezolid 600 mg IV/PO twice daily is recommended 1, 7
Treatment Algorithm
- Assessing infection severity and location is crucial in determining the appropriate treatment, with consideration of systemic symptoms and surgical site location 1, 3, 6
- Obtaining cultures before changing antibiotics is essential, including wound cultures and blood cultures if systemically ill 1, 6
- Selecting an appropriate antibiotic regimen based on location, such as piperacillin-tazobactam or ceftriaxone plus metronidazole for intestinal/genitourinary surgical sites, is critical 1
Important Considerations
- MRSA coverage is essential in post-surgical patients not responding to initial therapy, as MRSA is associated with a three-fold greater 90-day mortality rate compared to methicillin-susceptible S. aureus infections 5
- Local resistance patterns should guide empiric therapy choices, and patient-specific factors such as drug allergies and renal function must be considered 2